ATE309993T1 - 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten - Google Patents
4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonistenInfo
- Publication number
- ATE309993T1 ATE309993T1 AT98914096T AT98914096T ATE309993T1 AT E309993 T1 ATE309993 T1 AT E309993T1 AT 98914096 T AT98914096 T AT 98914096T AT 98914096 T AT98914096 T AT 98914096T AT E309993 T1 ATE309993 T1 AT E309993T1
- Authority
- AT
- Austria
- Prior art keywords
- optionally substituted
- custom
- ring
- hydrocarbon group
- bond
- Prior art date
Links
- 102000005157 Somatostatin Human genes 0.000 title 1
- 108010056088 Somatostatin Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
- 229960000553 somatostatin Drugs 0.000 title 1
- 150000002430 hydrocarbons Chemical group 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 108050001286 Somatostatin Receptor Proteins 0.000 abstract 1
- 102000011096 Somatostatin receptor Human genes 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005750 substituted cyclic group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10313897 | 1997-04-21 | ||
| JP31954597 | 1997-11-20 | ||
| PCT/JP1998/001797 WO1998047882A1 (en) | 1997-04-21 | 1998-04-20 | 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE309993T1 true ATE309993T1 (de) | 2005-12-15 |
Family
ID=26443792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98914096T ATE309993T1 (de) | 1997-04-21 | 1998-04-20 | 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6352982B1 (de) |
| EP (1) | EP0979227B1 (de) |
| KR (1) | KR20010012072A (de) |
| CN (1) | CN1252795A (de) |
| AT (1) | ATE309993T1 (de) |
| AU (1) | AU6854598A (de) |
| CA (1) | CA2285664A1 (de) |
| DE (1) | DE69832376T2 (de) |
| WO (1) | WO1998047882A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5265599A (en) | 1998-04-08 | 1999-11-01 | Takeda Chemical Industries Ltd. | Amine compounds, their production and their use as somatostatin receptor antagonists or agonists |
| US20010012620A1 (en) * | 1998-06-03 | 2001-08-09 | Rich Ivan N. | Method of reducing cell proliferation by inducing apoptosis in differentially selected cell subpopulations |
| CA2348159A1 (en) | 1998-10-20 | 2000-04-27 | Satoru Oi | Aromatic amine derivatives, their production and use |
| EP1295867A4 (de) * | 2000-06-28 | 2005-03-30 | Takeda Pharmaceutical | Biphenylverbindungen |
| EP1407782A4 (de) * | 2001-06-28 | 2004-10-20 | Takeda Chemical Industries Ltd | Mittel zur prävention/behandlung von funktionalen organerkrankungen und organischer dysfunktion |
| WO2003011276A1 (en) * | 2001-07-26 | 2003-02-13 | M's Science Corporation | Nf?b inhibitor |
| AU2002359359A1 (en) * | 2001-12-28 | 2003-07-24 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
| WO2004041286A1 (en) * | 2002-10-30 | 2004-05-21 | Smithkline Beecham Corporation | Benzodiazepine derivatives for the treatment of diabetes mellitus |
| CA2514547A1 (en) * | 2003-01-28 | 2004-08-12 | Takeda Pharmaceutical Company Limited | Receptor agonists |
| WO2004091628A1 (ja) * | 2003-04-18 | 2004-10-28 | Takeda Pharmaceutical Company Limited | 受容体拮抗剤 |
| FI20031454A0 (fi) | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja |
| WO2006123020A1 (en) * | 2005-05-18 | 2006-11-23 | Juvantia Pharma Ltd Oy | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| CA2685860A1 (en) * | 2007-05-10 | 2008-11-20 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| WO2010016552A1 (ja) | 2008-08-07 | 2010-02-11 | 武田薬品工業株式会社 | 過敏性腸症候群治療薬 |
| US10183940B2 (en) | 2014-11-14 | 2019-01-22 | Boehringer Ingelheim International Gmbh | Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists |
| JP7099717B2 (ja) | 2019-09-30 | 2022-07-12 | 株式会社理研バイオ | ソマトスタチン受容体 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3458501A (en) * | 1967-02-09 | 1969-07-29 | American Home Prod | 5-(m-sulfamoylphenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one |
| JPS5735576A (en) | 1980-07-18 | 1982-02-26 | Takeda Chem Ind Ltd | 4,1-benzoxazepin-3-acetic derivative and its production |
| WO1993007129A1 (fr) | 1991-10-11 | 1993-04-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Medicament utilise pour traiter l'osteoporose et compose de diazepine |
| US5428031A (en) | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| DE69332792T2 (de) | 1992-04-20 | 2004-01-15 | Takeda Chemical Industries Ltd | 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| JP3257731B2 (ja) * | 1993-09-29 | 2002-02-18 | 塩野義製薬株式会社 | 抗潰瘍活性を有するベンゾジアゼピン誘導体 |
| MX9702175A (es) | 1994-09-20 | 1997-06-28 | Pfizer | Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol. |
| TW401301B (en) | 1994-10-07 | 2000-08-11 | Takeda Chemical Industries Ltd | Antihypertriglyceridemic composition |
| JPH08259447A (ja) | 1995-03-24 | 1996-10-08 | Takeda Chem Ind Ltd | コレシストキニン拮抗剤 |
| FR2733984B1 (fr) * | 1995-05-10 | 1997-07-04 | Rhone Poulenc Rorer Sa | Derives de tryptamine, leur preparation et les medicaments les contenant |
| CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| WO1998000406A1 (en) * | 1996-07-02 | 1998-01-08 | Merck & Co., Inc. | Method for the treatment of preterm labor |
-
1998
- 1998-04-20 DE DE69832376T patent/DE69832376T2/de not_active Expired - Fee Related
- 1998-04-20 CA CA002285664A patent/CA2285664A1/en not_active Abandoned
- 1998-04-20 US US09/403,066 patent/US6352982B1/en not_active Expired - Fee Related
- 1998-04-20 KR KR1019997009676A patent/KR20010012072A/ko not_active Withdrawn
- 1998-04-20 EP EP98914096A patent/EP0979227B1/de not_active Expired - Lifetime
- 1998-04-20 AU AU68545/98A patent/AU6854598A/en not_active Abandoned
- 1998-04-20 CN CN98804380A patent/CN1252795A/zh active Pending
- 1998-04-20 AT AT98914096T patent/ATE309993T1/de not_active IP Right Cessation
- 1998-04-20 WO PCT/JP1998/001797 patent/WO1998047882A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010012072A (ko) | 2001-02-15 |
| DE69832376D1 (de) | 2005-12-22 |
| EP0979227B1 (de) | 2005-11-16 |
| US6352982B1 (en) | 2002-03-05 |
| DE69832376T2 (de) | 2006-08-03 |
| AU6854598A (en) | 1998-11-13 |
| CA2285664A1 (en) | 1998-10-29 |
| WO1998047882A1 (en) | 1998-10-29 |
| CN1252795A (zh) | 2000-05-10 |
| EP0979227A1 (de) | 2000-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69832376D1 (de) | 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten | |
| NO20023456L (no) | Nitrogenholdige forbindelser og farmasöytiske preparater inneholdende de samme | |
| ID21538A (id) | Turunan anilida, produksi dan pemakaiannya | |
| CA2167673A1 (en) | Condensed benzazepine derivative and pharmaceutical composition thereof | |
| MXPA02012314A (es) | Compuestos de 1,2-dihidropiridina, metodo de fabricacion y utilizacion de los mismos. | |
| ATE390404T1 (de) | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta | |
| DE69729583D1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren | |
| AU2001252596A1 (en) | Melanin concentrating hormone antagonists | |
| ES2189968T3 (es) | Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS. | |
| MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| AP2003002841A0 (en) | Quinazolines as MMP-13 inhibitors | |
| NO20033385D0 (no) | Fuserte heterocykliske forbindelser | |
| ATE304523T1 (de) | Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1- naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren | |
| NO953270L (no) | Fibrinogenreceptorantagonister | |
| EP0363085A3 (de) | Chemische Verbindungen | |
| EP1400513A4 (de) | Unsymmetrische cyclische diaminverbindung | |
| EP1466904A4 (de) | Biarylverbindung und dessen verwendung | |
| ES2126693T3 (es) | Derivado de triazina, su produccion y su uso. | |
| DE69328549D1 (de) | Für einen humanen serotoninrezeptor (5-ht4b) kodierende dns und ihre verwendung | |
| BR9408335A (pt) | Composto uso do mesmo e composição farmacêutica | |
| AP2000002008A0 (en) | Tetrahydroquinoline derivatives as glycine antagonists. | |
| DK0888379T3 (da) | Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf | |
| DK0847384T3 (da) | Carbamoylcarboxylsyreamider | |
| NO994135L (no) | Kinoksalindioner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |